REATA PHARMACEUTICALS INC

CUSIP: 75615P103 Class: Common Stock

Fayez Sarofim & Co's Holding History (CIK: 0000937729)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 30,329 Value ($000) $3,092 Avg Close — Range —
Q1 2023
Shares 30,329 Value ($000) $2,758 Avg Close — Range —
Q4 2022
Shares 30,329 Value ($000) $1,152 Avg Close — Range —
Q3 2022
Shares 30,329 Value ($000) $762 Avg Close — Range —
Q2 2022
Shares 30,329 Value ($000) $922 Avg Close — Range —
Q1 2022
Shares 30,329 Value ($000) $994 Avg Close — Range —
Q4 2021
Shares 30,329 Value ($000) $800 Avg Close — Range —
Q3 2021
Shares 30,129 Value ($000) $3,031 Avg Close — Range —
Q2 2021
Shares 30,129 Value ($000) $4,264 Avg Close — Range —
Q1 2021
Shares 30,129 Value ($000) $3,004 Avg Close — Range —
Q4 2020
Shares 30,129 Value ($000) $3,725 Avg Close — Range —
Q3 2020
Shares 30,129 Value ($000) $2,935 Avg Close — Range —
Q2 2020
Shares 30,129 Value ($000) $4,701 Avg Close — Range —
Q1 2020
Shares 30,129 Value ($000) $4,349 Avg Close — Range —
Q4 2019
Shares 30,129 Value ($000) $6,159 Avg Close — Range —
Q3 2019
Shares 30,129 Value ($000) $2,419 Avg Close — Range —
Q2 2019
Shares 30,129 Value ($000) $2,843 Avg Close — Range —
Q1 2019
Shares 30,129 Value ($000) $2,575 Avg Close — Range —
Q4 2018
Shares 30,129 Value ($000) $1,690 Avg Close — Range —
Q3 2018
Shares 30,129 Value ($000) $2,463 Avg Close — Range —
Q2 2018
Shares 30,129 Value ($000) $1,054 Avg Close — Range —